The Ins and Outs of Limited Distribution Specialty Drugs

Show Me the Money
It is also important to understand the financial incentives to limit distribution. Adding a single specialty pharmacy to a distribution network can cost a manufacturer $90,000 or more. Therefore, it can be cost prohibitive for a pharmaceutical company to have a large network of contracted pharmacies.

Additionally, many payers view more than 13 pharmacies in a network similarly to products available in open distribution. With more contracted pharmacies, payer reimbursement rates tend to go down, and patient populations spread out and become diluted.

In a limited distribution model, the pharmaceutical manufacturer is able to control supply and better influence patient services, such as risk evaluation and mitigation strategies, safety monitoring, and medication adherence.

Stand the Test
Although the practice of limited distribution is often debated, it is continuing to grow within the industry. It is necessary for many pharmacies to differentiate themselves to earn limited or exclusive distribution contracts.

Accreditations are just a single factor but are now mandatory for most payers. Therefore, pharmacies that can demonstrate expertise in specific patient populations or disease states have an advantage. 

Showing a manufacturer that the pharmacy can execute medication safety programs, patient care, and adherence programs to improve patient outcomes is imperative. Manufacturers do not automatically include the big specialty pharmacy players for their distribution networks.

Smaller pharmacies that can demonstrate this expertise are also able to earn those coveted contracts. For example, providing excellent services to patients who take an open distribution drug can demonstrate a pharmacy’s ability to take on a limited distribution medication.

The limited distribution model does limit some specialty pharmacies and typically cuts out retail pharmacies. However, remember that it is the duty of a pharmacist to provide clinical care to patients in practice settings, in which pharmacists are more accessible and arguably more influential than other health care providers. 

Therefore, the patient is better served by a pharmacy that can deliver specialized patient care, with pharmacists who are familiar with their unique disease states.

About the Author
Alex Toman attended Duquesne University, earning his Doctor of Pharmacy degree in 2011. Alex worked as a retail Pharmacist until 2015, at which time he transitioned into a clinical Pharmacist role within the specialty pharmacy industry. He is currently enrolled in the Masters of Science in Pharmacy Business Administration (MSPBA) program at the University of Pittsburgh, a 12-month, executive-style graduate education program designed for working professionals striving to be tomorrow’s leaders in the business of medicines.


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

An analysis of a quality improvement project at an oncology specialty pharmacy showed that pharmacist interventions can reduce financial toxicity for patients.
Doug Long, MBA, vice president of industry relations at IQVIA, discusses how vertical integration will affect health care delivery.
The conference will take place in conjunction with the 7th National Association of Specialty Pharmacy Annual Meeting & Expo.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.